Inactive Instrument

Company Pressure BioSciences, Inc. Other OTC

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Business Summary

Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The Company's BaroFold technology platform allows it to enter the bio-pharma contract services and GMP manufacturing equipment sector. It has also developed the scalable and pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be preserved using existing non-thermal technologies.

Sales per Business

USD in Million2021Weight2022Weight Delta
Hardware
44.0 %
1 55.1 % 1 44.0 % -31.07%
Consumables
14.9 %
0 13.7 % 0 14.9 % -6.20%
Contract Research Services
11.3 %
0 13.4 % 0 11.3 % -26.87%
Technical Support/Extended Service Contracts
10.1 %
0 5.9 % 0 10.1 % +46.22%
Agrochem Products
9.5 %
0 1.4 % 0 9.5 % +468.97%
Sample Preparation Accessories
7.6 %
0 7.0 % 0 7.6 % -5.71%
Shipping and Handling
2.4 %
0 2.5 % 0 2.4 % -17.65%
Other
0.1 %
0 0.8 % 0 0.1 % -88.24%

Sales per region

USD in Million2021Weight2022Weight Delta
North America
68.9 %
1 58.9 % 1 68.9 % +1.02%
Asia
22.8 %
1 26.7 % 0 22.8 % -26.22%
Europe
8.3 %
0 14.4 % 0 8.3 % -50.17%

Managers

Managers TitleAgeSince
Chief Executive Officer 73 78-07-31
Chief Tech/Sci/R&D Officer 70 06-04-23
Chief Tech/Sci/R&D Officer 59 06-04-02
Sales & Marketing 62 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 73 78-07-31
Director/Board Member 75 12-07-02
Director/Board Member 71 13-02-07
Chairman 68 11-06-20
Director/Board Member 53 12-07-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 75 0 0 98.82 %
Stock B 1 21,726,433 21,478,510 ( 98.86 %) 0
Stock C 0 8,601 0 0

Shareholders

NameEquities%Valuation
82,432 0.3202 % 14 426 $
60,089 0.2334 % 10 516 $
36,787 0.1429 % 6 438 $
33,159 0.1288 % 5 803 $
18,537 0.0720 % 3 244 $
16,104 0.0626 % 2 818 $
Archer Investment Corp.
0.0233 %
6,000 0.0233 % 1 050 $
Edmund Ting
0.003166 %
815 0.003166 % 143 $
Freedom Investors Corp.
0.000272 %
70 0.000272 % 12 $
NameEquities%Valuation
200 0.1376 % 35 $
20 0.0138 % 4 $
NameEquities%Valuation
65 0.8646 % 11 $
32 0.4256 % 6 $
26 0.3458 % 5 $
21 0.2793 % 4 $
20 0.2660 % 4 $
4 0.0532 % 1 $
NameEquities%Valuation
20 0.1752 % 4 $

Company contact information

Pressure BioSciences, Inc.

14 Norfolk Avenue

02375, South Easton

+

http://www.pressurebiosciences.com
address Pressure BioSciences, Inc.(PBIO)
  1. Stock Market
  2. Equities
  3. PBIO Stock
  4. PBIO Stock
  5. Company Pressure BioSciences, Inc.